PURE Bioscience, Inc. Increase (Decrease) in Interest Payable, Net
PURE Bioscience, Inc. (PURE) reported Increase (Decrease) in Interest Payable, Net of $291.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-06-15
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for the quarter ending 2026-04-30 was $102.00K, a 37.84% increase year-over-year.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for the quarter ending 2026-01-31 was $98.00K, a 48.48% increase year-over-year.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-10-31 was $91.00K, a 51.67% increase year-over-year.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-07-31 was $87.00K, a 77.55% increase year-over-year.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for fiscal 2025 was $287.00K, a 100.70% increase from fiscal 2024.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for fiscal 2024 was $143.00K, a 2283.33% increase from fiscal 2023.
- PURE Bioscience, Inc. increase (decrease) in interest payable, net for fiscal 2023 was $6.00K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2026-04-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-15 | $200.00K derived: sum of 2 quarters · filed 2026-06-15 | $291.00K 10-Q · filed 2026-06-15 | $378.00K derived: sum of 4 quarters · filed 2026-06-15 |
| 2026-01-31 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $189.00K 10-Q · filed 2026-03-17 | $276.00K derived: sum of 3 quarters · filed 2026-03-17 | $350.00K derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-10-31 | $91.00K 10-Q · filed 2025-12-15 | $178.00K derived: sum of 2 quarters · filed 2025-12-15 | $252.00K derived: sum of 3 quarters · filed 2026-06-15 | $318.00K derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-07-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $161.00K derived: sum of 2 quarters · filed 2026-06-15 | $227.00K derived: sum of 3 quarters · filed 2026-06-15 | $287.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-15 | $140.00K derived: sum of 2 quarters · filed 2026-06-15 | $200.00K 10-Q · filed 2026-06-15 | $249.00K derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-01-31 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $126.00K 10-Q · filed 2026-03-17 | $175.00K derived: sum of 3 quarters · filed 2026-03-17 | $213.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $60.00K 10-Q · filed 2025-12-15 | $109.00K derived: sum of 2 quarters · filed 2025-12-15 | $147.00K derived: sum of 3 quarters · filed 2025-12-15 | $182.00K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $87.00K derived: sum of 2 quarters · filed 2025-10-29 | $122.00K derived: sum of 3 quarters · filed 2025-10-29 | $143.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-16 | $73.00K derived: sum of 2 quarters · filed 2025-06-16 | $94.00K 10-Q · filed 2025-06-16 | |
| 2024-01-31 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-17 | $56.00K 10-Q · filed 2025-03-17 | ||
| 2023-10-31 | $21.00K 10-Q · filed 2024-12-16 | |||
| 2023-07-31 | $6.00K 10-K · filed 2024-10-29 |